Domainex Overview

  • Founded
  • 2001
Founded
  • Status
  • Private
  • Employees
  • 66
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $161K
Latest Deal Amount
  • Investors
  • 10

Domainex General Information

Description

Provider of drug discovery services intended to offer research facilities for developing advanced medicines. The company's services use biochemical binding technology for the development of oncology drugs, including inhibitors of the kinases and epigenetics related lysine methyltransferases, enabling healthcare professionals to tackle drug discovery programs against a wide range of drug targets.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Chesterford Research Park
  • Little Chesterford Saffron Walden
  • Essex CB10 1XL
  • England, United Kingdom
+44 01223 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Domainex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 23-Jan-2018 $161K 00.000 Completed Profitable
6. Grant 09-Jul-2014 00.000 00.000 Completed Profitable
5. Later Stage VC 14-Feb-2013 00.000 00.000 000.00 Completed Profitable
4. Later Stage VC 23-Feb-2010 00.000 00.000 000.00 Completed Profitable
3. Later Stage VC (Series A) 23-Apr-2008 00.000 00.000 Completed Startup
2. Later Stage VC 01-Jan-2007 $706K $1.1M Completed Startup
1. Early Stage VC 01-Dec-2002 $393K $393K Completed Startup
To view Domainex’s complete valuation and funding history, request access »

Domainex Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
B Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.000
B Ordinary 00,000 00.000000 000.00 000.00 00 000.00 00.000
A Ordinary 12,000 $0.015762 $47.29 $47.29 1x $47.29 2.62%
A Preferred 14,365 $0.015762 $22.07 $22.07 1x $22.07 3.14%
To view Domainex’s complete cap table history, request access »

Domainex Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of drug discovery services intended to offer research facilities for developing advanced medicines. The company
Biotechnology
Essex, United Kingdom
66 As of 2020
00.000
0000000000 00.000

00000000

prehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
0000 000000000
San Diego, CA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

00000000

uis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur
0000 000000000
Uppsala, Sweden
00 As of 0000
0000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Domainex Competitors (50)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vividion Therapeutics Venture Capital-Backed San Diego, CA 00 00000 00000000000 00000
00000000 000000000 Venture Capital-Backed Uppsala, Sweden 00 0000000000
00000000 000000000 Venture Capital-Backed Vienna, Austria 00.000 0000000000 00.000
000000 000000 Venture Capital-Backed South San Francisco, CA 00 00000 00000000000 00000
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
You’re viewing 5 of 50 competitors. Get the full list »

Domainex Executive Team (13)

Name Title Board Seat Contact Info
Tom Mander Ph.D Chief Executive Officer & Board Member
George Buckley Ph.D Senior Business Development Manager
Barry Knight Chief Financial Officer & Company Secretary
Laurence Pearl Ph.D Co-Founder & Chief Scientific Officer
Allan Marchington Ph.D Co-Founder
You’re viewing 5 of 13 executive team members. Get the full list »

Domainex Board Members (11)

Name Representing Role Since
Anthony Brampton Longbow Capital Co-Chairman 000 0000
Eddy Littler Ph.D Self Co-Chairman 000 0000
Edward Beckett Longbow Capital Board Member 000 0000
Frank Bury Self Board Member 000 0000
Judith Hills Ph.D Domainex Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Domainex Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Domainex Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Innovate UK Government 000 0000 000000 0
Medical Research Council Corporation 000 0000 000000 0
Juno Capital Venture Capital Minority 000 0000 000000 0
UCL Business University Minority 000 0000 000000 0
YFM Venture Finance PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »